Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Interventional Oncology Market, by Cancer Type
1.4.2 North America Interventional Oncology Market, by Product Type
1.4.3 North America Interventional Oncology Market, by End User
1.4.4 North America Interventional Oncology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Interventional Oncology Market by Cancer Type
3.1 North America Liver Cancer Market by Country
3.2 North America Lung Cancer Market by Country
3.3 North America Kidney Cancer Market by Country
3.4 North America Breast Cancer Market by Country
3.5 North America Prostate Cancer Market by Country
3.6 North America Bone Metastasis Market by Country
3.7 North America Others Market by Country
Chapter 4. North America Interventional Oncology Market by Product Type
4.1 North America Embolization Devices Market by Country
4.2 North America Ablation Devices Market by Country
4.3 North America Support Devices Market by Country
Chapter 5. North America Interventional Oncology Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Ambulatory Surgery Centers Market by Country
5.3 North America Research & Academic Institutes Market by Country
Chapter 6. North America Interventional Oncology Market by Country
6.1 US Interventional Oncology Market
6.1.1 US Interventional Oncology Market by Cancer Type
6.1.2 US Interventional Oncology Market by Product Type
6.1.3 US Interventional Oncology Market by End User
6.2 Canada Interventional Oncology Market
6.2.1 Canada Interventional Oncology Market by Cancer Type
6.2.2 Canada Interventional Oncology Market by Product Type
6.2.3 Canada Interventional Oncology Market by End User
6.3 Mexico Interventional Oncology Market
6.3.1 Mexico Interventional Oncology Market by Cancer Type
6.3.2 Mexico Interventional Oncology Market by Product Type
6.3.3 Mexico Interventional Oncology Market by End User
6.4 Rest of North America Interventional Oncology Market
6.4.1 Rest of North America Interventional Oncology Market by Cancer Type
6.4.2 Rest of North America Interventional Oncology Market by Product Type
6.4.3 Rest of North America Interventional Oncology Market by End User
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Regional Analysis
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations and Agreements:
7.5.5.2 Acquisitions and Mergers:
7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Becton, Dickinson and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 AngioDynamics, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Merit Medical Systems, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.10.1 Company Overview
Unique Offerings 
